Ivermectin cost insurers $130M in one year during the pandemic

January 25, 2022

Insurers paid for anti-parasite drug as a treatment for COVID-19 despite lack of evidence surrounding its effectiveness, according to a new study.

Join The Ecosystem

Price:

Free

First Name:* First Name Required

Last Name:* Last Name Required

Username:* Invalid Username

Email:* Invalid Email

Password:* Invalid Password

Password Confirmation:* Password Confirmation Doesn’t Match

No val

Please fix the errors above